Dec'05 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | ($5.6) | ($7.9) | $8.0 | $2.7 | $0.8 | $9.4 | $1.9 | $1.7 | $2.6 | $2.5 | $2.0 | $2.8 | $2.7 | $3.0 | $3.7 | $2.9 | $4.2 | $2.7 | $3.5 | $4.6 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Encompass Health Corporation's last 12-month EPS is $4.5, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Encompass Health Corporation's EPS growth was 28.6%. The average annual EPS growth rates for Encompass Health Corporation have been 5.5% over the past three years, 4.5% over the past five years.
Over the last year, Encompass Health Corporation's EPS growth was 28.6%, which is higher than industry growth of 0.6%. It indicates that Encompass Health Corporation's EPS growth is Good.